Guangji Pharmaceutical: Net loss of 75,515,100 yuan in the first half of 2025, a year-on-year decrease of 29.19%.

Guangji Pharmaceutical Industry Announcement: In the first half of 2025, the operating income was 284 million yuan, a year-on-year decrease of 4.08%. The net loss attributable to shareholders of the listed company was 75.5151 million yuan, a year-on-year decrease of 29.19%. The company plans not to distribute cash dividends, bonus shares, or increase capital through accumulated funds.